| Cardiovascular events and intensity of treatment in polycythemia vera R Marchioli, G Finazzi, G Specchia, R Cacciola, R Cavazzina, D Cilloni, ... New England Journal of Medicine 368 (1), 22-33, 2013 | 942 | 2013 |
| Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments V De Stefano, T Za, E Rossi, AM Vannucchi, M Ruggeri, E Elli, C Micò, ... haematologica 93 (3), 372-380, 2008 | 397 | 2008 |
| Mechanisms underlying the anti-inflammatory and immunosuppressive activity of ruxolitinib EM Elli, C Baratè, F Mendicino, F Palandri, GA Palumbo Frontiers in oncology 9, 1186, 2019 | 167 | 2019 |
| Hydroxyurea-related toxicity in 3,411 patients with Ph'-negative MPN. E Antonioli, P Guglielmelli, L Pieri, MC Finazzi, E Rumi, V Martinelli, ... American journal of hematology 87 (5), 552-554, 2012 | 160 | 2012 |
| Recurrent ETNK1 mutations in atypical chronic myeloid leukemia CB Gambacorti-Passerini, C Donadoni, A Parmiani, A Pirola, S Redaelli, ... Blood, The Journal of the American Society of Hematology 125 (3), 499-503, 2015 | 126 | 2015 |
| Life after ruxolitinib: reasons for discontinuation, impact of disease phase, and outcomes in 218 patients with myelofibrosis F Palandri, M Breccia, M Bonifacio, N Polverelli, EM Elli, G Benevolo, ... Cancer 126 (6), 1243-1252, 2020 | 125 | 2020 |
| Splanchnic vein thrombosis in myeloproliferative neoplasms: risk factors for recurrences in a cohort of 181 patients V De Stefano, AM Vannucchi, M Ruggeri, F Cervantes, A Alvarez-Larrán, ... Blood cancer journal 6 (11), e493-e493, 2016 | 103 | 2016 |
| High rate of recurrent venous thromboembolism in patients with myeloproliferative neoplasms and effect of prophylaxis with vitamin K antagonists V De Stefano, M Ruggeri, F Cervantes, A Alvarez-Larrán, A Iurlo, ... Leukemia 30 (10), 2032-2038, 2016 | 92 | 2016 |
| High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib T Barbui, AM Vannucchi, A Alvarez-Larran, A Iurlo, A Masciulli, ... Leukemia 35 (2), 485-493, 2021 | 90 | 2021 |
| A randomized double-blind trial of 3 aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia B Rocca, A Tosetto, S Betti, D Soldati, G Petrucci, E Rossi, A Timillero, ... Blood, The Journal of the American Society of Hematology 136 (2), 171-182, 2020 | 89 | 2020 |
| Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study S Verstovsek, AT Gerds, AM Vannucchi, HK Al-Ali, D Lavie, ... The Lancet 401 (10373), 269-280, 2023 | 84 | 2023 |
| Second cancer in Philadelphia negative myeloproliferative neoplasms (MPN-K). A nested case-control study T Barbui, A Ghirardi, A Masciulli, A Carobbio, F Palandri, N Vianelli, ... Leukemia 33 (8), 1996-2005, 2019 | 83 | 2019 |
| GIMEMA CMD-Working Party. Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments V De Stefano, T Za, E Rossi, AM Vannucchi, M Ruggeri, E Elli, C Mico, ... Haematologica 93 (3), 372-380, 2008 | 76 | 2008 |
| Leukocytosis is a risk factor for recurrent arterial thrombosis in young patients with polycythemia vera and essential thrombocythemia V De Stefano, T Za, E Rossi, AM Vannucchi, M Ruggeri, E Elli, C Mico, ... American journal of hematology 85 (2), 97-100, 2010 | 73 | 2010 |
| Clinical presentation and management practice of systemic mastocytosis. A survey on 460 Italian patients L Pieri, P Bonadonna, C Elena, C Papayannidis, FI Grifoni, M Rondoni, ... American Journal of Hematology 91 (7), 692-699, 2016 | 69 | 2016 |
| Iron toxicity–Its effect on the bone marrow A Isidori, L Borin, E Elli, R Latagliata, B Martino, G Palumbo, F Pilo, ... Blood Reviews 32 (6), 473-479, 2018 | 68 | 2018 |
| Increased risk of recurrent thrombosis in patients with essential thrombocythemia carrying the homozygous JAK2 V617F mutation V De Stefano, T Za, E Rossi, AM Vannucchi, M Ruggeri, E Elli, C Micò, ... Annals of hematology 89, 141-146, 2010 | 65 | 2010 |
| Pregnancy complications predict thrombotic events in young women with essential thrombocythemia ML Randi, I Bertozzi, E Rumi, C Elena, G Finazzi, N Vianelli, N Polverelli, ... American journal of hematology 89 (3), 306-309, 2014 | 63 | 2014 |
| A lower intensity of treatment may underlie the increased risk of thrombosis in young patients with masked polycythaemia vera F Lussana, A Carobbio, ML Randi, C Elena, E Rumi, G Finazzi, I Bertozzi, ... British journal of haematology 167 (4), 541-546, 2014 | 59 | 2014 |
| A prognostic model to predict survival after 6 months of ruxolitinib in patients with myelofibrosis M Maffioli, B Mora, S Ball, A Iurlo, EM Elli, MC Finazzi, N Polverelli, ... Blood advances 6 (6), 1855-1864, 2022 | 51 | 2022 |
